Copyright
©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1727-1742
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1727
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1727
Debray et al[25] | CF foundation classification[24] |
Hepatomegaly and/or splenomegaly- increased liver span at midclavicular line and spleen size in longitudinal coronal plane for age and sex, confirmed by ultrasonography | CF related liver disease with cirrhosis/portal hypertension (based on clinical exam/imaging, histology, laparoscopy) |
Abnormalities of liver function tests-elevated AST and ALT and GGT levels above the upper limit of normal with at least at 3 consecutive determinations over 12 months after excluding other causes of liver diseases | Liver involvement without cirrhosis/portal hypertension consisting of at least one of the following: (1) Persistent AST, ALT, GGT > 2 times upper limit of normal; (2) Intermittent elevations of the above laboratory values; (3) Steatosis (histologic determination); (4) Fibrosis (histologic determination); (5) Cholangiopathy (based on ultrasound, MRI, CT, ERCP); and (6) Ultrasound abnormalities not consistent with cirrhosis |
Ultrasonographic evidence of coarseness, nodularity, increased echogenicity, or portal hypertension | Preclinical: No evidence of liver disease on clinical examination, imaging or laboratory values |
Liver biopsy showing cirrhosis |
- Citation: Valamparampil JJ, Gupte GL. Cystic fibrosis associated liver disease in children. World J Hepatol 2021; 13(11): 1727-1742
- URL: https://www.wjgnet.com/1948-5182/full/v13/i11/1727.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i11.1727